| 111 |
Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
|
2019 |
| 112 |
Correlation Between the Overall Disease Prognosis and The Percentage of Both (Trisomy 12 and CD49d Expression) in Patients with Chronic Lymphocytic Leukemia (CLL)
|
2019 |
| 113 |
DFT and Thermal Decomposition Studies
on Gemcitabine |
2019 |
| 114 |
Long-Term Evaluation of Imatinib´s Effect on Bone
Marrow Fibrosis in Patients with Chronic Myeloid
Leukemia |
2019 |
| 115 |
Long-Term Evaluation of Imatinib´s Effect on Bone Marrow Fibrosis in Patients with Chronic Myeloid Leukemia
|
2019 |
| 116 |
Pediatric Osteosarcoma of Extremities: a 15-year Experience from a Tertiary Care Cancer Center in Upper Egypt |
2019 |
| 117 |
Prognostic Value of c-Myc Immunohistochemical Expression in Muscle Invasive Urothelial Carcinoma of the Urinary Bladder: A Retrospective Study
|
2019 |
| 118 |
Prognostic Value of Telomere Length in Peripheral Blood Leucocytes in Breast Cancer Patients (South Egypt Cancer Institute Experience) |
2019 |
| 119 |
The Prognostic Implication of CD49d Expression by Flow Cytometry and Trisomy 12 Detection by Fluorescent in situ Hybridization in Chronic Lymphocytic Leukemia |
2019 |
| 120 |
The Prognostic Significance of Pre and Post
Treatment Neutrophil to Lymphocyte Ratio in
Breast Cancer Patients
|
2019 |
